Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression

被引：38

作者：

Jin, Wook ^{[1
]}

机构：

[1] Gachon Univ, Sch Med, Dept Biochem, Lab Mol Dis & Cell Regulat, Incheon 406840, South Korea

来源：

JOURNAL OF CLINICAL MEDICINE | 2020年 / 9卷 / 05期

基金：

新加坡国家研究基金会;

关键词：

PARK7 (DJ-1); therapeutic target; apoptosis; redox sensor; chemoresistance; FAMILIAL PARKINSONS-DISEASE; CELL LUNG-CARCINOMA; ANDROGEN RECEPTOR; INDUCED APOPTOSIS; HEPATOCELLULAR-CARCINOMA; PROTEOMIC ANALYSIS; GASTRIC-CANCER; UP-REGULATION; DIFFERENTIAL-DIAGNOSIS; POSITIVE CORRELATION;

D O I：

10.3390/jcm9051256

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The expression of PARK7 is upregulated in various types of cancer, suggesting its potential role as a critical regulator of the pathogenesis of cancer and in the treatment of cancer and neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and Huntington disease. PARK7 activates various intracellular signaling pathways that have been implicated in the induction of tumor progression, which subsequently enhances tumor initiation, continued proliferation, metastasis, recurrence, and resistance to chemotherapy. Additionally, secreted PARK7 has been identified as a high-risk factor for the pathogenesis and survival of various cancers. This review summarizes the current understanding of the correlation between the expression of PARK7 and tumor progression.

引用

页数：18

共 50 条

[21] DJ-1 (PARK7) mRNA levels in idiopathic Parkinson's disease
Bandopadhyay, R.
Kumaran, R.
Vandrovcova, J.
Kingsbury, A.
Lees, A.
MOVEMENT DISORDERS, 2008, 23 (01) : S11 - S11
[22] Calreticulin: a potential anti-cancer therapeutic target
Sun, Jing
Mu, Hongxiang
Dai, Keren
Yi, Lan
PHARMAZIE, 2017, 72 (09): : 503 - 510
[23] DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7
Di Nottia, M.
Masciullo, M.
Verrigni, D.
Petrillo, S.
Modoni, A.
Rizzo, V.
Di Giuda, D.
Rizza, T.
Niceta, M.
Torraco, A.
Bianchi, M.
Santoro, M.
Bentivoglio, A. R.
Bertini, E.
Piemonte, F.
Carrozzo, R.
Silvestri, G.
CLINICAL GENETICS, 2017, 92 (01) : 18 - 25
[24] PARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseases
Kolisek, Martin
Montezano, Augusto C.
Sponder, Gerhard
Anagnostopoulou, Aikaterini
Vormann, Juergen
Touyz, Rhian M.
Aschenbach, Joerg R.
CLINICAL SCIENCE, 2015, 129 (12) : 1143 - 1150
[25] DJ-1 as a human oncogene and potential therapeutic target
Cao, Ji
Lou, Siyue
Ying, Meidan
Yang, Bo
BIOCHEMICAL PHARMACOLOGY, 2015, 93 (03) : 241 - 250
[26] PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells
Lago-Baameiro, Nerea
Santiago-Varela, Maria
Camino, Tamara
Silva-Rodriguez, Paula
Bande, Manuel
Blanco-Teijeiro, Maria Jose
Pardo, Maria
Pineiro, Antonio
TUMORI JOURNAL, 2023, 109 (01): : 47 - 53
[27] NEUROPROTECTIVE EFFECT OF DJ-1 (PARK7) ON FOCAL CEREBRAL ISCHEMIA AND REPERFUSION IN RATS
Kitamura, Yoshihisa
Yanagida, Takashi
Takata, Kazuyuki
Taniguchi, Takashi
Tooyama, Ikuo
Morikawa, Shigehiro
Inubushi, Toshio
Taira, Takahiro
Ariga, Hiroyoshi
JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 344 - 344
[28] Cullin 7 in tumor development: a novel potential anti-cancer target
Li, Yumiao
Zang, Aiming
Fu, Jiejun
Jia, Youchao
NEOPLASMA, 2021, 68 (03) : 572 - 579
[29] Maternal PARK7 (DJ-1) levels and the preterm premature rupture of membranes: Correspondence
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 19 (01) : 87 - 87
[30] Inhibition by pesticides of the DJ-1/Park7 protein related to Parkinson disease.
Mathas, Nicolas
Poncet, Gabrielle
Laurent, Catherine
Larigot, Lucie
Le-Grand, Beatrice
Gonis, Elodie
Birman, Serge
Galardon, Erwan
Sari, Marie-Agnes
Tiouaini, Mounira
Nioche, Pierre
Barouki, Robert
Coumoul, Xavier
Mansuy, Daniel
Dairou, Julien
TOXICOLOGY, 2023, 487

← 1 2 3 4 5 →